Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-24

Clinical Trial Update: Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools

View source ↗

Summary

A completed study in northeastern France assessing severity risk factors and prognostic tools for hantavirus nephropathy and hantavirus infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Hantavirus Nephropathy, Hantavirus Infection | Status: COMPLETED